Delivery Order SPE2DB22D1202-SPE2DB25FVJE1
- Not listed
- This delivery order awards $1,227.97 to AmerisourceBergen Drug Corp for the supply of Carboprost 250 micrograms per milliliter vials under a firm fixed price arrangement. The contract was awarded on July 2, 2025, with an ultimate completion date of July 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded through open competition. The funding agency is the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carboprost 250 micrograms per milliliter vials. This is a firm fixed-price delivery order with a ceiling value of $1,060.71 and an ultimate completion date of August 21, 2025. The award was made without a set-aside designation, indicating competitive selection, and the place of performance is AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CARBOPROST 250 MCG/ML VIALML. The contract has a completion date of February 5, 2024 and a potential value of $3,253.69. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of CARBOPROST 250 MCG/ML VIALML medical supplies. The contract has a ceiling value of $1,060.71 and is a Firm Fixed Price (FFP) contract with a performance period through May 28, 2025. This award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Carboprost 250 mcg/mL vials, a medication used for various medical purposes. The contract has a ceiling value of $1,227.97 and a completion date of July 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,699.50 to AmerisourceBergen Drug Corp for Prostin VR Pedi 500 mcg/mL, a pharmaceutical product used in pediatric healthcare applications. The contract, which is classified as a firm fixed price delivery order with no set-aside designation, was awarded on August 15, 2025, and is scheduled for completion by August 18, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,656.00 by the Defense Logistics Agency's Medical Supply Chain division on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under a larger indefinite delivery vehicle and requires performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract involved no set-aside designation,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $58,103.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of the same day. This competitive, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,250.47 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVJE1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,513.18 to AmerisourceBergen Drug Corp for Carboprost 250 micrograms per milliliter vials, with an ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. This delivery order is a child contract under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle, which encompasses a broad range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains to support military medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/25/25 |